Resistance mechanisms in KRAS-G12C-mutated cancer

被引：0
|
作者：
Gassa, Asmae [1 ]
Ozkan, Filiz [2 ,3 ]
Ast, David [4 ]
Wahlers, Thorsten [1 ]
Bruns, Christiane [5 ]
Alakus, Hakan [5 ]
机构：
[1] Univ Klinikum Koln AoR, Klin & Poliklin Herzchirurg Herzchirurg Intens Me, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Med Mannheim, Sekt Pneumol, Med Klin 1, Mannheim, Germany
[3] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA
[4] Univ Cologne, Inst Pathol, Univ Klinikum Koln AoR, Mol,Pathol, Cologne, Germany
[5] Univ Klinikum Koln AoR, Klin & Poliklin Allgemein Viszeral & Tumorchirug, Cologne, Germany
来源：
ONKOLOGE | 2021年 / 27卷 / 12期
关键词：
D O I：
10.1007/s00761-021-01038-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1243 / 1244
页数：2
相关论文
共 50 条
  • [41] Real world outcomes in KRAS G12C mutated metastatic colorectal cancer: An Australian retrospective analysis
    John, Alexius
    Cui, Wanyuan
    Muhandiramge, Jaidyn
    Johnson, Jeslin
    Lee, Margaret
    Dunn, Catherine
    Shapiro, Jeremy
    Loft, Matthew
    McKendrick, Joseph
    To, Yat Hang
    Wong, Hui Li
    Gibbs, Peter
    Tie, Jeanne
    Wong, Rachel
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 39 - 40
  • [42] How to manage KRAS G12C-mutated advanced non-small-cell lung cancer
    Ricciuti, Biagio
    Mira, Alessia
    Andrini, Elisa
    Scaparone, Pietro
    Michelina, Sandra Vietti
    Pecci, Federica
    Cantini, Luca
    De Giglio, Andrea
    Lamberti, Giuseppe
    Ambrogio, Chiara
    Metro, Giulio
    DRUGS IN CONTEXT, 2022, 11
  • [43] Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease
    Keane, Fergus
    Chou, Joanne F.
    Walch, Henry
    Schoenfeld, Joshua
    Singhal, Anupriya
    Cowzer, Darren
    Harrold, Emily
    O'Connor, Catherine A.
    Park, Wungki
    Varghese, Anna
    El Dika, Imane
    Balogun, Fiyinfolu
    Yu, Kenneth H.
    Capanu, Marinela
    Schultz, Nikolaus
    Yaeger, Rona
    O'Reilly, Eileen M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (09):
  • [44] Genomic Profiles and Potential Determinants of Response and Resistance in KRAS p.G12C-mutated NSCLC Treated With Sotorasib
    Skoulidis, F.
    Schuler, M.
    Wolf, J.
    Barlesi, F.
    Price, T.
    Dy, G.
    Govindan, R.
    Borghaei, H.
    Falchook, G.
    Li, B.
    Ramalingam, S.
    Sacher, A.
    Spira, A.
    Takahashi, T.
    Anderson, A.
    Ang, A.
    Dai, T.
    Flesher, D.
    Cifuentes, P.
    Velcheti, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S929 - S930
  • [45] Immunogenomics of Clinical Resistance to KRAS G12C Inhibition
    Woodcock, M.
    Tsai, Y. S.
    Azam, S. H.
    Thorne, L. B.
    Kanchi, K. L.
    Parker, J. S.
    Vincent, B. G.
    Pecot, C. V.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S599 - S600
  • [46] Correction: The KRAS-G12C inhibitor: activity and resistance
    Jiao Liu
    Rui Kang
    Daolin Tang
    Cancer Gene Therapy, 2023, 30 : 1715 - 1715
  • [47] Overcoming adaptive resistance to KRAS G12C inhibitors
    Adachi, Yuta
    Niitsu, Hiroaki
    Yamaguchi, Rui
    Ebi, Hiromichi
    CANCER SCIENCE, 2024, 115 : 110 - 110
  • [48] EMT is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C mutant NSCLC
    Adachi, Yuta
    Ito, Kentaro
    Kimura, Ryo
    Yamaguchi, Rui
    Ebi, Hiromichi
    ANNALS OF ONCOLOGY, 2021, 32 : S307 - S307
  • [49] Adaptive resistance to KRAS-G12C inhibitors through AXL activation in KRAS-G12C mutant tumor cells
    Morimoto, Kenji
    Yamada, Tadaaki
    Hirai, Soichi
    Katayama, Yuki
    Yano, Seiji
    Horinaka, Mano
    Sakai, Toshiyuki
    Tokuda, Shinsaku
    Takayama, Koichi
    CANCER SCIENCE, 2024, 115 : 111 - 111
  • [50] AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells
    Morimoto, Kenji
    Yamada, Tadaaki
    Hirai, Soichi
    Katayama, Yuki
    Fukui, Sarina
    Sawada, Ryo
    Tachibana, Yusuke
    Matsui, Yohei
    Nakamura, Ryota
    Ishida, Masaki
    Kawachi, Hayato
    Kunimasa, Kei
    Sasaki, Takaaki
    Nishida, Makoto
    Furuya, Naoki
    Watanabe, Satoshi
    Shiotsu, Shinsuke
    Nishioka, Naoya
    Horinaka, Mano
    Sakai, Toshiyuki
    Uehara, Hisanori
    Yano, Seiji
    Son, Bo-Kyung
    Tokuda, Shinsaku
    Takayama, Koichi
    CANCER LETTERS, 2024, 587
12345